Tuberous Sclerosis
Also known as: TSC / Tuberous Sclerosis Complex (TSC) / Tuberous Sclerosis Complex / Epiloya / Brain sclerosis / Tuberous sclerosis syndrome (disorder) / Epiloia
Drug | Drug Name | Drug Description |
---|---|---|
DB09061 | Cannabidiol | An active cannabinoid used as an adjunctive treatment for the management of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome and symptomatic relief of moderate to severe neuropathic pain or other painful conditions, like cancer. |
DB00877 | Sirolimus | An mTOR inhibitor immunosuppressant used to prevent organ transplant rejections, treat lymphangioleiomyomatosis, and treat adults with perivascular epithelioid cell tumors. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00877 | Sirolimus | 1 | Completed | 1 |
DB01590 | Everolimus | 1 / 2 | Completed | 5 |
DB00641 | Simvastatin | 1 / 2 | Completed | 1 |
DB00877 | Sirolimus | 1 / 2 | Completed | 2 |
DB00945 | Acetylsalicylic acid | 2 | Unknown Status | 1 |
DB01590 | Everolimus | 2 | Completed | 4 |
DB01590 | Everolimus | 2 | Unknown Status | 1 |
DB05087 | Ganaxolone | 2 | Completed | 1 |
DB00571 | Propranolol | 2 | Completed | 1 |
DB08839 | Serotonin | 2 | Not Yet Recruiting | 1 |
DB01104 | Sertraline | 2 | Not Yet Recruiting | 1 |
DB00877 | Sirolimus | 2 | Completed | 4 |
DB00877 | Sirolimus | 2 | Recruiting | 2 |
DB00877 | Sirolimus | 2 | Terminated | 1 |
DB00877 | Sirolimus | 2 | Unknown Status | 1 |
DB01080 | Vigabatrin | 2 | Completed | 1 |
DB01590 | Everolimus | 2 / 3 | Unknown Status | 1 |
DB00877 | Sirolimus | 2 / 3 | Completed | 1 |
DB00877 | Sirolimus | 2 / 3 | Recruiting | 1 |
DB01080 | Vigabatrin | 2 / 3 | Recruiting | 1 |
DB09061 | Cannabidiol | 3 | Completed | 2 |
DB01590 | Everolimus | 3 | Active Not Recruiting | 1 |
DB01590 | Everolimus | 3 | Completed | 2 |
DB05087 | Ganaxolone | 3 | Enrolling by Invitation | 1 |
DB09061 | Cannabidiol | 4 | Recruiting | 1 |
DB00254 | Doxycycline | 4 | Completed | 1 |